AR016683A1 - Composicion de suministro de droga solida, anhidra, proceso y uso de una pluralidad de particulas inorganicas porosas compuestas de hidroxipatita ceramicapara su preparacion. - Google Patents
Composicion de suministro de droga solida, anhidra, proceso y uso de una pluralidad de particulas inorganicas porosas compuestas de hidroxipatita ceramicapara su preparacion.Info
- Publication number
- AR016683A1 AR016683A1 ARP980105798A ARP980105798A AR016683A1 AR 016683 A1 AR016683 A1 AR 016683A1 AR P980105798 A ARP980105798 A AR P980105798A AR P980105798 A ARP980105798 A AR P980105798A AR 016683 A1 AR016683 A1 AR 016683A1
- Authority
- AR
- Argentina
- Prior art keywords
- composition
- preparation
- inorganic particles
- oily
- hydroxypathic
- Prior art date
Links
- 239000007787 solid Substances 0.000 title abstract 3
- 239000003814 drug Substances 0.000 title abstract 2
- 229940079593 drug Drugs 0.000 title abstract 2
- 239000010954 inorganic particle Substances 0.000 title abstract 2
- 238000000034 method Methods 0.000 title abstract 2
- 239000000126 substance Substances 0.000 abstract 3
- 239000013543 active substance Substances 0.000 abstract 2
- 238000012377 drug delivery Methods 0.000 abstract 1
- 239000002245 particle Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1617—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/005—Enzyme inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/143—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1611—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Inorganic Chemistry (AREA)
- Biophysics (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Diabetes (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Hematology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Una composicion de suministro de droga para la administracion oral en forma anhidra solida de una sustancia grasosa, aceitosa, o pegajosa y una sustanciafarmacéuticamente activa o una sustancia farmacéuticamente activa que en sí misma es grasosa,ace itosa o pegajosa, donde la composicion tiene una pluralidadde partículas porosas inorganicas de tamano pequeno incorporadas, con cantidades de sustancias grasosas, aceitosas o pegajosas y características deliberacion rápida; y un proceso y usode dic has partículas inorgánicas porosas que contienen sustancias grasosas, aceitosas o pegajosas para la preparacion dela composicion de suministro de droga solida, anhidra.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE9704400A SE9704400D0 (sv) | 1997-11-28 | 1997-11-28 | Porous inorganic particles as carriers for drug substances |
Publications (1)
Publication Number | Publication Date |
---|---|
AR016683A1 true AR016683A1 (es) | 2001-07-25 |
Family
ID=20409177
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP980105798A AR016683A1 (es) | 1997-11-28 | 1998-11-16 | Composicion de suministro de droga solida, anhidra, proceso y uso de una pluralidad de particulas inorganicas porosas compuestas de hidroxipatita ceramicapara su preparacion. |
Country Status (26)
Country | Link |
---|---|
US (1) | US6558703B1 (es) |
EP (1) | EP1032370B1 (es) |
JP (1) | JP2001524513A (es) |
KR (1) | KR20010032557A (es) |
CN (1) | CN1280492A (es) |
AR (1) | AR016683A1 (es) |
AT (1) | ATE256453T1 (es) |
AU (1) | AU752044B2 (es) |
BR (1) | BR9814751A (es) |
CA (1) | CA2311780A1 (es) |
DE (1) | DE69820674T2 (es) |
DK (1) | DK1032370T3 (es) |
ES (1) | ES2210840T3 (es) |
HU (1) | HUP0100303A3 (es) |
ID (1) | ID24700A (es) |
IL (1) | IL136146A0 (es) |
NO (1) | NO20002719L (es) |
NZ (1) | NZ504353A (es) |
PL (1) | PL340927A1 (es) |
PT (1) | PT1032370E (es) |
RU (1) | RU2219907C2 (es) |
SE (1) | SE9704400D0 (es) |
SK (1) | SK6602000A3 (es) |
TW (1) | TW524694B (es) |
WO (1) | WO1999027912A1 (es) |
ZA (1) | ZA9810463B (es) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9924334D0 (en) * | 1999-10-15 | 1999-12-15 | Secr Defence | Pharmaceutical products and methods of fabrication therefor |
ES2287110T3 (es) * | 2000-04-11 | 2007-12-16 | Sankyo Company, Limited | Composicion farmaceutica estabilizada que contiene un bloqueador de calcio consistente en azelnidipina. |
IT1319202B1 (it) | 2000-10-12 | 2003-09-26 | Nicox Sa | Farmaci per le malattie a base infiammatoria. |
US6462021B1 (en) | 2000-11-06 | 2002-10-08 | Astrazeneca Ab | Use of low molecular weight thrombin inhibitor |
DK1569912T3 (en) | 2002-12-03 | 2015-06-29 | Pharmacyclics Inc | 2- (2-hydroxybiphenyl-3-yl) -1h-benzoimidazole-5-carboxamidine derivatives as factor VIIa inhibitors. |
KR101207553B1 (ko) | 2005-06-02 | 2012-12-03 | (주)씨앤팜 | 금속 이중층 수산화물을 포함하는 생체 주사제용 약물 담체 |
TW200736245A (en) * | 2005-11-29 | 2007-10-01 | Sankyo Co | Acid addition salts of optically active dihydropyridine derivatives |
TW200806648A (en) * | 2005-11-29 | 2008-02-01 | Sankyo Co | Acid addition salts of dihydropyridine derivatives |
JP5027410B2 (ja) * | 2005-12-13 | 2012-09-19 | 株式会社サンギ | ユビキノン含有組成物 |
US20100040668A1 (en) * | 2006-01-12 | 2010-02-18 | Rutgers, The State University Of New Jersey | Biomimetic Hydroxyapatite Composite Materials and Methods for the Preparation Thereof |
US8287914B2 (en) * | 2006-01-12 | 2012-10-16 | Rutgers, The State University Of New Jersey | Biomimetic hydroxyapatite synthesis |
GB0909460D0 (en) | 2009-06-02 | 2009-07-15 | Intrinsiq Materials Global Ltd | Mesoporus material |
CN111389345A (zh) | 2013-02-01 | 2020-07-10 | 格雷斯公司 | 作为用于液体技术的载体的多孔硅胶 |
WO2015040212A1 (en) * | 2013-09-20 | 2015-03-26 | Tillotts Pharma Ag | Delayed release pharmaceutical formulation |
CN104133014B (zh) * | 2014-07-16 | 2015-09-16 | 广州法尔麦兰药物技术有限公司 | 一种考察布洛伪麻缓释制剂释放度的方法 |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB8413191D0 (en) | 1984-05-23 | 1984-06-27 | Beecham Group Plc | Pharmaceutical composition |
GB8713263D0 (en) | 1987-06-05 | 1987-07-08 | Unilever Plc | Spheroidal silica |
US5055307A (en) | 1988-12-29 | 1991-10-08 | Asahi Kagaku Kogyo Kabushiki Kaisha | Slow release drug delivery granules and process for production thereof |
US5149523A (en) * | 1989-06-20 | 1992-09-22 | Aktiebolaget Hassle | Polystyrenesulfonate-drug complex and solid dosage forms thereof |
US5443459A (en) * | 1991-01-30 | 1995-08-22 | Alza Corporation | Osmotic device for delayed delivery of agent |
US5834496A (en) * | 1991-12-02 | 1998-11-10 | Sepracor, Inc. | Methods for treating hypertension using optically pure S(-) felodipine |
US5947893A (en) * | 1994-04-27 | 1999-09-07 | Board Of Regents, The University Of Texas System | Method of making a porous prothesis with biodegradable coatings |
US6096324A (en) * | 1995-06-13 | 2000-08-01 | Laboratory Skin Care | Methods of delivering materials into the skin, and compositions used therein |
-
1997
- 1997-11-28 SE SE9704400A patent/SE9704400D0/xx unknown
-
1998
- 1998-10-27 TW TW087117781A patent/TW524694B/zh not_active IP Right Cessation
- 1998-11-16 AR ARP980105798A patent/AR016683A1/es not_active Application Discontinuation
- 1998-11-16 ZA ZA9810463A patent/ZA9810463B/xx unknown
- 1998-11-18 US US09/214,318 patent/US6558703B1/en not_active Expired - Fee Related
- 1998-11-19 IL IL13614698A patent/IL136146A0/xx unknown
- 1998-11-19 AT AT98957268T patent/ATE256453T1/de not_active IP Right Cessation
- 1998-11-19 SK SK660-2000A patent/SK6602000A3/sk unknown
- 1998-11-19 JP JP2000522898A patent/JP2001524513A/ja active Pending
- 1998-11-19 KR KR1020007005802A patent/KR20010032557A/ko not_active Application Discontinuation
- 1998-11-19 ES ES98957268T patent/ES2210840T3/es not_active Expired - Lifetime
- 1998-11-19 PL PL98340927A patent/PL340927A1/xx unknown
- 1998-11-19 BR BR9814751-0A patent/BR9814751A/pt not_active IP Right Cessation
- 1998-11-19 ID IDW20000937A patent/ID24700A/id unknown
- 1998-11-19 HU HU0100303A patent/HUP0100303A3/hu unknown
- 1998-11-19 AU AU13563/99A patent/AU752044B2/en not_active Ceased
- 1998-11-19 DK DK98957268T patent/DK1032370T3/da active
- 1998-11-19 CN CN98811634A patent/CN1280492A/zh active Pending
- 1998-11-19 WO PCT/SE1998/002089 patent/WO1999027912A1/en not_active Application Discontinuation
- 1998-11-19 PT PT98957268T patent/PT1032370E/pt unknown
- 1998-11-19 EP EP98957268A patent/EP1032370B1/en not_active Expired - Lifetime
- 1998-11-19 DE DE69820674T patent/DE69820674T2/de not_active Expired - Lifetime
- 1998-11-19 CA CA002311780A patent/CA2311780A1/en not_active Abandoned
- 1998-11-19 RU RU2000113731/15A patent/RU2219907C2/ru not_active IP Right Cessation
- 1998-11-19 NZ NZ504353A patent/NZ504353A/en unknown
-
2000
- 2000-05-26 NO NO20002719A patent/NO20002719L/no unknown
Also Published As
Publication number | Publication date |
---|---|
AU1356399A (en) | 1999-06-16 |
TW524694B (en) | 2003-03-21 |
DK1032370T3 (da) | 2004-03-15 |
KR20010032557A (ko) | 2001-04-25 |
PT1032370E (pt) | 2004-05-31 |
EP1032370A1 (en) | 2000-09-06 |
BR9814751A (pt) | 2000-10-03 |
WO1999027912A1 (en) | 1999-06-10 |
ZA9810463B (en) | 1999-05-21 |
NZ504353A (en) | 2001-10-26 |
JP2001524513A (ja) | 2001-12-04 |
RU2219907C2 (ru) | 2003-12-27 |
CA2311780A1 (en) | 1999-06-10 |
DE69820674T2 (de) | 2004-09-30 |
DE69820674D1 (de) | 2004-01-29 |
AU752044B2 (en) | 2002-09-05 |
HUP0100303A2 (hu) | 2001-08-28 |
PL340927A1 (en) | 2001-03-12 |
ATE256453T1 (de) | 2004-01-15 |
IL136146A0 (en) | 2001-05-20 |
CN1280492A (zh) | 2001-01-17 |
HUP0100303A3 (en) | 2004-03-29 |
SK6602000A3 (en) | 2001-01-18 |
ID24700A (id) | 2000-08-03 |
EP1032370B1 (en) | 2003-12-17 |
NO20002719D0 (no) | 2000-05-26 |
US6558703B1 (en) | 2003-05-06 |
NO20002719L (no) | 2000-07-28 |
ES2210840T3 (es) | 2004-07-01 |
SE9704400D0 (sv) | 1997-11-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR016683A1 (es) | Composicion de suministro de droga solida, anhidra, proceso y uso de una pluralidad de particulas inorganicas porosas compuestas de hidroxipatita ceramicapara su preparacion. | |
AR011728A1 (es) | FORMULACIoN FARMACÉUTICA DE GRÁNUKOS ENTÉRICOS DE FLUOXETINA Y SU USO PARA PREPARAR UN MEDICAMENTO. | |
ES2183841T3 (es) | Formas de dosificacion para administrar un farmasco en una formulacion lquidid. | |
ES2172655T3 (es) | Formas galenicas estables al almacenamiento. | |
CO4960652A1 (es) | Formas de dosificacion farmaceuticas solidas | |
AR002754A1 (es) | Composición farmacéutica que comprende bacterias lactobacillus viables micro-encapsuladas, y uso de la composición para preparar de un medicamento | |
AR005282A1 (es) | Composición farmacéutica oral en la forma de un comprimido de unidades múltiples, uso de la misma para la preparación de medicamnetos, y procedimiento para su manufactura. | |
AR002009A1 (es) | Composicion farmaceutica, procedimiento para la manufactura de un polvo de proliposoma como el utilizado en dicha composicion, procedimiento para lamanufactura de dicha composicion, uso de dicha composicion farmaceutica en la manufactura de un medicamento y dispositivo inhalador de polvo seco. | |
SE9700135D0 (sv) | New formulation | |
BR9808888A (pt) | Formas de dosagem e método de melhorar disfunção erétil masculina | |
IT8719064A0 (it) | Compressa per uso farmaceutico atta al rilascio in tempi successivi di sostanze attive. | |
ES2052016T3 (es) | Composicion emulsionada. | |
ES2162517T3 (es) | Composicion farmaceutica que comprende una combinacion de metformin y fibrato y su uso en la preparacion de medicamentos destinados a reducir la hiperglicemia. | |
IT1296980B1 (it) | Capsula doppia come forma farmaceutica per la somministrazione di principi attivi in terapie multiple | |
ES2126536B1 (es) | "preparado farmaceutico para administracion intranasal y procedimientopara su produccion". | |
ES2191682T3 (es) | Nueva formulacion farmaceutica. | |
EA200600598A1 (ru) | Лекарственные формы замедленного высвобождения | |
MY118371A (en) | Tetrahydrolipstatin containing compositions | |
ID23806A (id) | Komposisi-komposisi farmasi untuk pemberian oral yang terdiri dari bahan aktif dan siklodekstrin | |
EE04238B1 (et) | Asendatud 1,2,3,4-tetrahüdronaftaleeni derivaadid, meetod selle valmistamiseks, nimetatud terapeutilise toimega aineid sisaldavad ravimkoostised ja nimetatud aktiivsete ühendite kasutamine teraapias | |
CL2008003938A1 (es) | Uso de escitalopram o de una sal farmaceuticamente aceptable del mismo para preparar un medicamento util en el tratamiento del desorden de estres postraumatico (divisional sol. 1799-00). | |
ES2145992T3 (es) | Forma medicamentosa que sirve para administrar sustancias activas a las heridas. | |
CO4940406A1 (es) | Composiciones de paracetamol de accion rapida | |
ES2161292T3 (es) | Composicion de higiene oral. | |
AR028023A1 (es) | Una composicion farmaceutica para el tratamiento de la hiperlipidemia y el uso de dicha composicion para la preparacion de medicamentos |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA | Abandonment or withdrawal |